It appears that your browser is not supported by XPLAN. Currently supported browsers are
- Internet Explorer 11 or above
- Firefox
- Chrome
- Safari
Please enter your user ID and password to gain access to AMP Xplan
CURRENT VERSION 20.7.129
IMPORTANT NOTICES:
North - Advantage Replacement Funds (Wealthsolver & IPS) – NEW 21/01/2021 |
We have identified the following issues relating to the Advantage Replacement Funds:
Iress are in the process of adding these funds into Wealthsolver without the pricing and performance data. This will allow advisers to run comparisons on these funds. Iress will update the remaining fund details in the future and work with the individual fund managers to have IPS data updated, however no date has been finalised as to when this will be completed. We apologise for any inconvenience |
MyNorth Guarantee Redesign – 30/11/2020 |
To support the new MyNorth Guarantees, a reference guide has been made available to provide an overview of the steps users need to take in XPLAN, to include guarantee fees in the projections when creating a XTOOLS+ CALM scenario.
You can access the guide on Portal > Standards > QAFs & Standards > Advising on guaranteed products – specifically North and MyNorth guarantees > Tools and resources or Adviser IQ > Standards A-Z list > Advising on guaranteed products - North & MyNorth guarantees > Tools and templates. |
AMP Model Portfolio’s Update – 24/11/2020 |
Xplan has been updated with the latest model portfolios changes, for details please refer to: |
Life Insurance APL update – 02/11/2020 |
In response to insurance sector changes AMP undertook a rigorous review and tender process to ensure the panel remained competitive. There is now a common APL across all licensees. Please refer to FAQ’s about the changes located at: Portal > Research > Insurance Research > Life Insurance updates or Adviser IQ > Tapin and Research > Research > Insurance Research You can access the new updated APL at: Portal > Research > Insurance Research > Approved Product Lists or Adviser IQ > Tapin and Research > Research > Approved Product List |
North Datafeed issue - 07/10/2020 |
The issue affecting North fee rebate transactions was fixed for new transactions from 24/08/2020. Historical transactions prior to this date were not covered in the fix.
AMP are currently investigating a solution to apply a fix for the historical transactions. We apologise for any inconvenience |
Advantage Funds Model Portfolios - 17/09/2020 |
Given the closure and downgrade of the Advantage Funds, the Advantage Funds models cannot be used for new clients. Advisers may consider using the wholesale fund models to manage new clients’ assets as an alternative. For clients who currently use the Advantage Funds models to manage investments, advisers should read the Product update – Advantage funds along with other product and advice communications when considering the appropriate action for your clients. You can access the product update on portal > Research > Investment Research > Research Updates. |
XPLAN Coronavirus Response 05/05/2020 |
The government have introduced a number of changes to cushion the economic impact of the coronavirus. We have identified the following changes as having an impact on Xtools projections:
Legislative Rates have been updated to reflect items 3 and 4 above:
IRESS will publish a separate guide on how to accommodate changes 1,2 and 5 in CALM/Xtools+ projections please refer to IRESS community for more details. |
FDS Data Announcement |
The fee data provided is for reference only. AMP has detected issues with the accuracy of some of the FDS data provided. Invoices created in the Salesforce Invoicing and Payments system, for ongoing service agreements, may be missing from your FDS data in Portal, COIN or Xplan
You must check the amounts provided for accuracy against the original product information and with the relevant product manufacturers. You are responsible for preparing your FDS under the Corporations Act 2001 and you must be satisfied with the accuracy of the data contained in your FDS.
|
For Xplan enquiries please contact adtech@amp.com.au or phone 1300 367 800 opt 3 / opt 2